isoproterenol has been researched along with tolbutamide in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 32 (68.09) | 18.7374 |
1990's | 4 (8.51) | 18.2507 |
2000's | 4 (8.51) | 29.6817 |
2010's | 7 (14.89) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Brooker, G; Linden, J | 1 |
Day, JA; Patel, YC; Ramseur, R; Samols, E; Weir, GC | 1 |
Chideckel, EW; Davidson, MB; Ensinck, J; Goodner, CJ; Koerker, DJ; Palmer, J | 1 |
Lerner, RL | 1 |
Collins, JE; Krop, S; Weiss, LR | 1 |
Burr, IM; Nelson, JH; Nies, AS; Perry, JM; Young, JL | 1 |
Hasselblatt, A; Lenzen, S; Panten, U | 1 |
Curtis, GP; Lucchesi, BR; Setchfield, J | 1 |
Sumi, T; Ui, M | 1 |
Fong, JC; Hong, PK; Leu, SJ | 1 |
Jahn, P; Loge, O; Losert, W | 1 |
Ikeda, M | 1 |
Cornish, EJ; Miller, RC | 1 |
Hodgins, DS; Kuo, JF; Kuo, WN | 1 |
Loubatières, A; Loubatières-Mariani, MM | 1 |
Loubatiéres, A; Mariani, MM | 1 |
Hayakawa, T; Kanamori, T; Nagatsu, T | 1 |
Ebert, R; Hillebrandt, O; Schwabe, U | 1 |
Ariëns, EJ | 1 |
Deckert, T; Lauridsen, UB; Madsen, SN; Mogensen, P | 1 |
Mandelbaum, I; Morgan, CR | 1 |
Dykes, JR; Majid, PA; Saxton, C; Sharma, B; Taylor, SH | 1 |
Bonner-Weir, S; Clore, ET; Weir, GC; Zmachinski, CJ | 1 |
Ferguson, DC; Hoenig, M; Matschinsky, FM | 1 |
Hagino, Y; Tachibana, M | 1 |
Kanatsuka, A; Kumagai, A; Makino, H; Osegawa, M | 1 |
Safronova, VG; Saxon, ME | 1 |
Abdel-Hamid, M; Ammon, HP; Enz, G; Rao, PG | 1 |
Bailbe, D; Giroix, MH; Kergoat, M; Picon, L; Portha, B | 1 |
Blum, JW | 1 |
Beard, JC; Halter, JB; Judzewitsch, R; Pfeifer, MA; Porte, D | 1 |
Graf, R; Halter, JB; Pfeifer, MA; Porte, D | 1 |
Chapa, J; Loubatieres-Mariani, MM; Manteghetti, M; Puech, R | 1 |
Capito, K; Hansen, SE; Thams, P | 1 |
Downing, R; Heald, KA; Jay, TR | 1 |
Fullerton, DA; McIntyre, RC; Meldrum, DR; Sheridan, BC | 1 |
Brixius, K; Fässler, R; Fleischmann, B; Herr, C; Hescheler, J; Lasek, K; Noegel, AA; Sasse, P; Schröder, R; Schwinger, RH; Smyth, N; Ullrich, S; Yun, F | 1 |
Bond, R; Choisy, SC; El Haou, S; Hancox, JC; James, AF; Khaliulin, I; Kim, SJ; Lin, H; Milnes, JT; Suleiman, MS; Zhang, H | 1 |
2 review(s) available for isoproterenol and tolbutamide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Oral antidiabetics. Dose, plasma concentration and effect].
Topics: Acetohexamide; Adrenergic beta-Antagonists; Animals; Blood Glucose; Carbutamide; Chemical Phenomena; Chemistry; Chlorpropamide; Cyclic AMP; Diazoxide; Drug Antagonism; Drug Synergism; Glucagon; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Isoproterenol; Kidney; Liver; Sulfonamides; Sulfonylurea Compounds; Theophylline; Tolbutamide | 1969 |
1 trial(s) available for isoproterenol and tolbutamide
Article | Year |
---|---|
Inotropic effects of tolbutamide in man.
Topics: Adult; Blood Glucose; Clinical Trials as Topic; Electrocardiography; Glucose; Heart; Heart Rate; Humans; Insulin; Isoproterenol; Male; Phonocardiography; Statistics as Topic; Stimulation, Chemical; Time Factors; Tolbutamide | 1975 |
44 other study(ies) available for isoproterenol and tolbutamide
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
The positive inotropic action of sulfonylureas. A mechanism independent of cyclic adenosine 3',5'-monophosphate.
Topics: Adenylyl Cyclases; Animals; Atrial Function; Cyclic AMP; Dose-Response Relationship, Drug; Glyburide; Guinea Pigs; Heart; Isoproterenol; Male; Myocardial Contraction; Myocardium; Rabbits; Rats; Species Specificity; Tolbutamide; Ventricular Function | 1978 |
Modulation of pancreatic somatostatin by adrenergic and cholinergic agonism and by hyper- and hypoglycemic sulfonamides.
Topics: Acetylcholine; Animals; Diazoxide; Dogs; Epinephrine; Glucagon; Insulin; Insulin Secretion; Isoproterenol; Male; Pancreas; Phentolamine; Propranolol; Somatostatin; Sulfonamides; Tolbutamide | 1978 |
Somatostatin blockade of acute and chronic stimuli of the endocrine pancreas and the consequences of this blockade on glucose homeostasis.
Topics: Animals; Blood Glucose; Depression, Chemical; Female; Glucagon; Glucose; Haplorhini; Homeostasis; Hypoglycemia; Insulin; Insulin Secretion; Islets of Langerhans; Isoproterenol; Male; Papio; Peptides; Rats; Secretin; Stimulation, Chemical; Tolbutamide | 1975 |
The augmentation effects of secretin on the insulin responses to known stimuli: specificity for glucose.
Topics: Adult; Arginine; Blood Glucose; Glucagon; Glucose; Humans; Insulin; Isoproterenol; Kinetics; Male; Secretin; Tolbutamide | 1977 |
Effects of prolonged tolbutamide treatment on plasma glucose concentrations and isoproterenol-induced cardiac lesions in rats.
Topics: Animals; Blood Glucose; Body Weight; Drug Interactions; Female; Heart Diseases; Isoproterenol; Male; Organ Size; Rats; Tolbutamide; Ventricular Fibrillation | 1977 |
Thyroxine treatment and insulin secretion in the rat.
Topics: Animals; Blood Glucose; Glucose; Glycolysis; Insulin; Insulin Secretion; Isoproterenol; Male; Pancreas; Perfusion; Pyruvates; Rats; Thyroxine; Tolbutamide | 1975 |
The cardiac pharmacology of tolbutamide.
Topics: Animals; Blood Pressure; Cats; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Electric Stimulation; Female; Heart; In Vitro Techniques; Injections, Intra-Arterial; Isoproterenol; Male; Myocardial Contraction; Norepinephrine; Papillary Muscles; Purkinje Fibers; Rabbits; Species Specificity; Stimulation, Chemical; Theophylline; Tolbutamide | 1975 |
Potentiation of the adrenergic beta-receptor-mediated insulin secretion in pertussis-sensitized rats.
Topics: Animals; Blood Glucose; Diazoxide; Epinephrine; Glucagon; Glucose; Hydrocortisone; Insulin; Insulin Antibodies; Isoproterenol; Male; Norepinephrine; Pertussis Vaccine; Phentolamine; Phenylephrine; Rats; Receptors, Adrenergic; Time Factors; Tolbutamide; Whooping Cough | 1975 |
Enhanced lipolysis in 3T3-L1 adipocytes following prolonged exposure to tolbutamide.
Topics: 1-Methyl-3-isobutylxanthine; 3T3 Cells; Adipose Tissue; Adrenocorticotropic Hormone; Animals; Bucladesine; Cell Differentiation; Colforsin; Cycloheximide; Glycerol; Isoproterenol; Kinetics; Lipolysis; Mice; Tolbutamide | 1991 |
[Comparison of the beta-cytotropic effect of glymidine sodium (glycodiazine), glucagon, and isopropylnoradrenaline in rats].
Topics: Adenosine Monophosphate; Adrenergic beta-Antagonists; Animals; Barbiturates; Blood Glucose; Diazoxide; Drug Interactions; Ethers; Glucagon; Hypoglycemic Agents; Insulin; Insulin Secretion; Iodine Radioisotopes; Isoproterenol; Male; Norepinephrine; Pancreas; Phentolamine; Photometry; Pyrimidines; Rats; Stimulation, Chemical; Sulfonamides; Theophylline; Time Factors; Tolbutamide | 1973 |
[Plasma insulin levels in endocrine diseases. 4. Effects of adrenergic receptor agents on plasma insulin levels].
Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Arginine; Depression, Chemical; Epinephrine; Female; Humans; Insulin; Isoproterenol; Male; Methoxamine; Phenoxybenzamine; Phentolamine; Phenylephrine; Propranolol; Receptors, Adrenergic; Stimulation, Chemical; Sympatholytics; Sympathomimetics; Tolbutamide | 1973 |
Letter: Comparison of the relaxant effects of isoprenaline and tolbutamide on uterine and tracheal muscle.
Topics: Albuterol; Animals; Cats; Epinephrine; Female; Guinea Pigs; In Vitro Techniques; Isoproterenol; Muscle, Smooth; Norepinephrine; Tolbutamide; Trachea; Uterus | 1973 |
Regulation by various hormones and agents of adenosine-3',5'-monophosphate levels in islets of Langerhans of rats.
Topics: Adenine; Adrenergic beta-Antagonists; Adrenocorticotropic Hormone; Animals; Cresols; Cyclic AMP; Epinephrine; Glucagon; Glucose; Guanosine Triphosphate; Hormones; In Vitro Techniques; Islets of Langerhans; Isoproterenol; Leucine; Phenformin; Phenoxybenzamine; Phentolamine; Propanolamines; Propranolol; Propylamines; Prostaglandins; Rats; Receptors, Adrenergic; Secretin; Sotalol; Theophylline; Thyrotropin; Tolbutamide; Tritium | 1974 |
In vitro secretion of insulin after glucose, sulphonylureas, adrenergic and cholinergic substances studied by isolated perfused rat pancreas.
Topics: Acetylcholine; Animals; Atropine; Diazoxide; Epinephrine; Glucagon; Glucose; Glyburide; Heptoses; In Vitro Techniques; Insulin; Insulin Secretion; Isoproterenol; Ketoses; Norepinephrine; Pancreas; Parasympathomimetics; Perfusion; Phenoxybenzamine; Practolol; Propranolol; Sulfonylurea Compounds; Theophylline; Tolbutamide | 1974 |
[Recent pharmacologic aspects of sulfamides modifying insulin secretion (hypoglycemic and hyperglycemic sulfamides)].
Topics: Animals; Catecholamines; Diazoxide; Dogs; Dose-Response Relationship, Drug; Drug Antagonism; Drug Synergism; Glucose; Glyburide; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Isoproterenol; Pancreas; Pancreatectomy; Phenoxybenzamine; Propranolol; Rats; Tolbutamide | 1973 |
Adenosine 3',5'-monophosphate-dependent protein kinase and amylase secretion from rat parotid gland.
Topics: Amylases; Animals; Cyclic AMP; In Vitro Techniques; Isoproterenol; Parotid Gland; Protein Kinases; Rats; Structure-Activity Relationship; Sulfonylurea Compounds; Time Factors; Tolbutamide | 1974 |
Role of calcium and cyclic adenosine 3',5'-monophosphate in the antilipolytic effect of tolbutamide and glibenclamide.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adipose Tissue; Adrenocorticotropic Hormone; Animals; Bucladesine; Calcium; Carboxylic Acids; Cyclic AMP; Epinephrine; Glucagon; Glyburide; Isoproterenol; Lipid Metabolism; Male; Norepinephrine; Rats; Theophylline; Tolbutamide | 1974 |
Insulin response to glucose, tolbutamide, secretin, and isoprenaline in maturity-onset diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Body Weight; Diabetes Mellitus; Female; Glucose; Humans; Injections, Intravenous; Insulin; Isoproterenol; Male; Middle Aged; Secretin; Stimulation, Chemical; Time Factors; Tolbutamide | 1972 |
Pancreatic blood flow and its relationship to insulin secretion during extracorporeal circulation.
Topics: Animals; Atropine; Dogs; Extracorporeal Circulation; Glucose; Insulin; Insulin Secretion; Isoproterenol; Pancreas; Regional Blood Flow; Secretory Rate; Tolbutamide | 1969 |
Plasma insulin in heart disease.
Topics: Cardiac Surgical Procedures; Heart Diseases; Heart Failure; Humans; Insulin; Insulin Secretion; Isoproterenol; Myocardial Infarction; Pancreas; Phentolamine; Secretory Rate; Sympathetic Nervous System; Tolbutamide | 1971 |
Islet secretion in a new experimental model for non-insulin-dependent diabetes.
Topics: Animals; Arginine; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Glucagon; Glucose; Insulin; Insulin Secretion; Islets of Langerhans; Isoproterenol; Male; Pregnancy; Rats; Somatostatin; Theophylline; Tolbutamide | 1981 |
Pharmacological modifications of insulin release in vitro from fuel-responsive transplantable insulinomas.
Topics: Acetylcholine; Adenoma, Islet Cell; Animals; Blood Glucose; Glucagon; Glucose; Insulin; Insulinoma; Isoproterenol; Kidney; Neoplasm Transplantation; Organ Size; Pancreatic Neoplasms; Perfusion; Rats; Rats, Inbred Strains; Somatostatin; Tolbutamide | 1984 |
Amylase release from parotid glands of hypothyroid rats. I. Altered responsiveness to adrenergic agents.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Amylases; Animals; Bucladesine; Hypothyroidism; Isoproterenol; Male; Parotid Gland; Rats; Rats, Inbred Strains; Sympathomimetics; Tolbutamide | 1982 |
Effects of sulfonylureas on membrane-bound low Km cyclic AMP phosphodiesterase in rat fat cells.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acetohexamide; Adipose Tissue; Animals; Buformin; Glyburide; Isoproterenol; Kinetics; Male; Rats; Rats, Inbred Strains; Sulfonylurea Compounds; Tolbutamide | 1982 |
The rest-dependent depression of action potential duration in rabbit myocardium and the possible role of the transient outward current. A pharmacological analysis.
Topics: Action Potentials; Aminopyridines; Animals; Calcium; Depression, Chemical; Electric Stimulation; Guanylyl Imidodiphosphate; Heart; Imines; Ion Channels; Isoproterenol; Papillary Muscles; Potassium; Rabbits; Rest; Time Factors; Tolbutamide | 1982 |
Thiol-dependent and non-thiol-dependent stimulations of insulin release.
Topics: Animals; Bucladesine; Calcimycin; Calcium; Diamide; Dose-Response Relationship, Drug; Female; Glucose; Glutathione; Glyburide; Glyceraldehyde; Insulin; Insulin Secretion; Islets of Langerhans; Isoproterenol; Leucine; Male; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Tolbutamide | 1984 |
Glucose insensitivity and amino-acid hypersensitivity of insulin release in rats with non-insulin-dependent diabetes. A study with the perfused pancreas.
Topics: Acetylcholine; Amino Acids; Animals; Arginine; Blood Glucose; Diabetes Mellitus, Experimental; Glucose; Glyceraldehyde; Insulin; Insulin Secretion; Islets of Langerhans; Isoproterenol; Keto Acids; Leucine; Mannose; Rats; Rats, Inbred Strains; Theophylline; Tolbutamide | 1983 |
Insulin suppressive effects of aminotetralin analogs and of dopamine.
Topics: Animals; Cattle; Dopamine; Insulin; Insulin Antagonists; Insulin Secretion; Isoproterenol; Male; Naphthalenes; Phentolamine; Sodium Chloride; Tetrahydronaphthalenes; Tolbutamide | 1984 |
Insulin responses to nonglucose stimuli in non-insulin-dependent diabetes mellitus during a tolbutamide infusion.
Topics: Adult; Aged; Arginine; Blood Glucose; Diabetes Mellitus; Glucose; Humans; Insulin; Insulin Secretion; Isoproterenol; Male; Middle Aged; Tolbutamide | 1982 |
Potentiation of insulin secretion to nonglucose stimuli in normal man by tolbutamide.
Topics: Arginine; Blood Glucose; Drug Synergism; Glucose; Humans; Infusions, Parenteral; Insulin; Insulin Secretion; Islets of Langerhans; Isoproterenol; Male; Regression Analysis; Tolbutamide | 1980 |
A different action of hypothermia on insulin release from the isolated, perfused rat pancreas, depending on the stimulating agent.
Topics: Acetylcholine; Animals; Body Temperature; Cold Temperature; Glucose; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Isoproterenol; Kinetics; Perfusion; Rats; Tolbutamide | 1980 |
Production of [3H]choline-labelled metabolites from endogenously 3H-labelled phosphatidylcholine in mouse pancreatic islets.
Topics: Animals; Carbachol; Cells, Cultured; Choline; Cyclohexanones; Diazoxide; Glucose; Glycerylphosphorylcholine; Insulin; Insulin Secretion; Islets of Langerhans; Isoproterenol; Kinetics; Lysophosphatidylcholines; Male; Mice; Mice, Inbred Strains; Phosphatidylcholines; Potassium Chloride; Radioisotope Dilution Technique; Rats; Sodium Fluoride; Succinates; Tetradecanoylphorbol Acetate; Tolbutamide; Tritium | 1996 |
Effect of donor age on porcine insulin secretion.
Topics: Aging; Animals; Carbachol; Cells, Cultured; Glucose; Insulin; Insulin Secretion; Islets of Langerhans; Isoproterenol; Swine; Theophylline; Tolbutamide | 1997 |
KATP channels contribute to beta- and adenosine receptor-mediated pulmonary vasorelaxation.
Topics: Acetylcholine; Adenosine; Adenylyl Cyclases; Animals; ATP-Binding Cassette Transporters; Colforsin; Cromakalim; Cyclic AMP; Cyclic GMP; Glyburide; In Vitro Techniques; Isoproterenol; KATP Channels; Kinetics; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroprusside; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Purinergic P1; Tolbutamide; Vasodilation | 1997 |
Loss of annexin A7 leads to alterations in frequency-induced shortening of isolated murine cardiomyocytes.
Topics: Animals; Annexin A7; Caffeine; Calcium; Cardiotonic Agents; Central Nervous System Stimulants; Colforsin; Embryo, Mammalian; Female; Gene Targeting; Glucose; Homeostasis; Hypoglycemic Agents; Immunoblotting; Insulin; Insulin Secretion; Islets of Langerhans; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle Contraction; Myocardium; Patch-Clamp Techniques; Tolbutamide | 2001 |
Activation of glibenclamide-sensitive ATP-sensitive K+ channels during β-adrenergically induced metabolic stress produces a substrate for atrial tachyarrhythmia.
Topics: Adrenergic beta-Agonists; Animals; Disease Models, Animal; Electrophysiologic Techniques, Cardiac; Glyburide; Heart Atria; Heart Conduction System; Isoproterenol; KATP Channels; Male; Potassium Channel Blockers; Rats; Stress, Physiological; Tachycardia; Time Factors; Tolbutamide | 2012 |